Showing results (191-200 of 2,909) with videos related to

Sort By:
Pageof 291
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2022
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin-2 by Supporting Antioxidant Defense in Systemic Lupus ErythematosusRyo Hisada, Nobuya Yoshida, Seo Yeon K Orite, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2018
Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal ModelsAlan J Nixon, Matthew W Grol, Hayley M Lang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
Multiple Nonspecific Sites of Joint Pain Outside the Knees Develop in Persons With Knee PainDavid T Felson, Jingbo Niu, Emily K Quinn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 27, 2016
The Association of Vibratory Perception and Muscle Strength With the Incidence and Worsening of Knee Instability: The Multicenter Osteoarthritis StudyNajia Shakoor, David T Felson, Jingbo Niu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2017
Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1Jianhua Liu, Celine C Berthier, J Michelle Kahlenberg
Arthritis & Rheumatology (Hoboken, N.J.)|May 17, 2017
Association of Increased F4/80high Macrophages With Suppression of Serum-Transfer Arthritis in Mice With Reduced FLIP in Myeloid CellsQi-Quan Huang, Robert Birkett, Renee E Doyle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2017
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid ArthritisMark C Genovese, Joel M Kremer, Ronald F van Vollenhoven, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 17, 2017
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK-1 Inhibitor, After Short-Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa TrialsFrédéric Vanhoutte, Minodora Mazur, Oleksandr Voloshyn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?Kornelis S M van der Geest, Maria Sandovici, Yannick van Sleen, et al.
Pageof 291